HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ran You Selected Research
Ran You Research Topics
Disease
14
Neoplasms (Cancer)
05/2024 - 07/2017
7
Emphysema
11/2022 - 03/2014
6
Hepatocellular Carcinoma (Hepatoma)
01/2024 - 08/2019
5
Inflammation (Inflammations)
03/2023 - 11/2011
3
Breast Neoplasms (Breast Cancer)
03/2024 - 01/2016
3
Fibrosis (Cirrhosis)
03/2024 - 01/2020
3
Acute Kidney Injury (Acute Renal Failure)
03/2023 - 01/2020
3
Retinal Perforations
03/2021 - 01/2019
3
COVID-19
01/2021 - 10/2020
3
Pneumonia (Pneumonitis)
10/2019 - 03/2014
3
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2018 - 01/2018
2
Triple Negative Breast Neoplasms
05/2024 - 03/2024
2
Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
02/2024 - 08/2023
2
Thrombosis (Thrombus)
01/2023 - 01/2023
2
Glioma (Gliomas)
01/2023 - 07/2017
2
Lung Neoplasms (Lung Cancer)
11/2022 - 01/2018
2
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
01/2022 - 01/2020
2
Atrophy
01/2020 - 01/2018
2
Autoimmune Diseases (Autoimmune Disease)
01/2020 - 01/2018
2
Infections
01/2017 - 11/2015
2
Alzheimer Disease (Alzheimer's Disease)
12/2012 - 05/2012
1
Kidney Diseases (Kidney Disease)
03/2024
1
Cataract (Cataracts)
01/2024
1
Cicatrix (Scar)
01/2024
1
Skin Diseases (Skin Disease)
08/2023
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell)
07/2023
1
Sepsis (Septicemia)
03/2023
1
Cardiomyopathies (Cardiomyopathy)
03/2023
1
Vascular Diseases (Vascular Disease)
02/2023
1
Optic Nerve Injuries
02/2023
1
Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2023
1
Carcinogenesis
01/2023
1
Mitochondrial Diseases (Mitochondrial Disease)
01/2022
1
Bites and Stings (Sting)
01/2022
1
Graves Disease (Basedow Disease)
01/2022
1
Retinal Degeneration
01/2022
1
Hypertension (High Blood Pressure)
01/2020
1
Atherosclerosis
01/2020
Drug/Important Bio-Agent (IBA)
6
Smoke
IBA
10/2019 - 03/2014
5
Biomarkers (Surrogate Marker)
IBA
07/2023 - 07/2017
4
Immune Checkpoint Inhibitors
IBA
01/2024 - 01/2023
4
Proteins (Proteins, Gene)
FDA Link
07/2023 - 05/2006
4
Cytokines
IBA
01/2023 - 11/2015
3
lenvatinib
IBA
01/2024 - 01/2023
3
Retinaldehyde (Retinal)
IBA
02/2023 - 01/2018
3
Soot
IBA
11/2022 - 10/2015
2
2- ((7- nitrobenzo(c)(1,2,5)oxadiazol- 4- yl)thio)pyridine 1-oxide
IBA
03/2023 - 01/2022
2
Sorafenib (BAY 43-9006)
FDA Link
01/2023 - 01/2023
2
DNA (Deoxyribonucleic Acid)
IBA
01/2023 - 11/2011
2
Antineutrophil Cytoplasmic Antibodies (ANCA)
IBA
01/2022 - 01/2020
2
Coloring Agents (Dyes)
IBA
03/2021 - 01/2019
2
Antibodies
IBA
01/2021 - 10/2020
2
Interferons
IBA
01/2021 - 10/2020
2
Protein Kinases (Protein Kinase)
IBA
08/2019 - 11/2015
2
Phosphotransferases (Kinase)
IBA
08/2019 - 11/2011
1
Photosensitizing Agents (Photosensitizers)
IBA
05/2024
1
Polylactic Acid-Polyglycolic Acid Copolymer
IBA
05/2024
1
Peptides (Polypeptides)
IBA
05/2024
1
temoporfin
IBA
05/2024
1
Melitten (Melittin)
IBA
05/2024
1
1-phenyl-3,3-dimethyltriazene (PDT)
IBA
05/2024
1
Nanoparticle Drug Delivery System
IBA
03/2024
1
Fibrillar Collagens
IBA
03/2024
1
RNA (Ribonucleic Acid)
IBA
03/2024
1
Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)
IBA
03/2024
1
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
02/2024
1
Ketorolac
IBA
01/2024
1
HLA-DR Antigens (HLA-DR)
IBA
08/2023
1
Surface Antigens (Surface Antigen)
IBA
08/2023
1
Immunoglobulins (Immunoglobulin)
IBA
07/2023
1
regorafenib
IBA
01/2023
1
Heterogeneous-Nuclear Ribonucleoprotein K
IBA
01/2023
1
Mechanistic Target of Rapamycin Complex 1
IBA
01/2023
1
RNA Precursors (Precursor, mRNA)
IBA
01/2023
1
Mechanistic Target of Rapamycin Complex 2
IBA
01/2023
1
Heterogeneous-Nuclear Ribonucleoproteins (Informatin)
IBA
01/2023
1
Lactic Acid (Lactate)
FDA Link
Generic
11/2022
1
Particulate Matter
IBA
11/2022
1
camrelizumab
IBA
01/2022
1
4-phenylbutyric acid (Buphenyl)
FDA Link
01/2022
1
manganese(III)-tetrakis(4-benzoic acid)porphyrin
IBA
01/2022
1
epidermal growth factor receptor VIII
IBA
01/2022
1
blinatumomab
IBA
01/2022
1
Adenosine Triphosphate (ATP)
IBA
01/2022
1
Autoantibodies
IBA
01/2022
1
Cisplatin (Platino)
FDA Link
Generic
01/2022
1
Long-Acting Thyroid Stimulator (LATS)
IBA
01/2022
1
N-Methylaspartate (NMDA)
IBA
01/2022
1
Stem Cell Factor
IBA
01/2022
1
Therapeutic Uses
IBA
01/2022
1
Death Domain Receptors
IBA
01/2022
1
microplasmin
IBA
01/2021
1
Toll-Like Receptor 9
IBA
01/2020
Therapy/Procedure
10
Therapeutics
05/2024 - 11/2015
4
Immunotherapy
01/2022 - 10/2020
1
Photochemotherapy (Photodynamic Therapy)
05/2024
1
Drug Therapy (Chemotherapy)
01/2024
1
Craniotomy
01/2023
1
Intravitreal Injections
01/2022
1
Vitrectomy
03/2021